Abstract Aim Demoralization, which is characterized by helplessness, hopelessness, and the loss of meaning, has gained increasing attention in psychiatry and palliative care. Robinson et al. developed the Demoralization Scale‐II (DS‐II) to assess this construct in a brief and reliable format. However, a validated Japanese version has not been developed to date. The purpose of this study was to develop a Japanese version of the DS‐II (DS‐II‐J) and to evaluate its psychometric properties in cancer patients. Methods A total of 147 cancer patients from 3 acute care hospitals in Japan were included in the study. Participants completed the DS‐II‐J, Patient Health Questionnaire‐9 (PHQ‐9), Generalized Anxiety Disorder 7‐item Scale (GAD‐7), and Edmonton Symptom Assessment System Revised Version (ESAS‐r). Internal consistency was assessed using Cronbach's α . Convergent validity was evaluated by examining correlations with the PHQ‐9, GAD‐7, and ESAS‐r. Confirmatory factor analysis (CFA) and exploratory factor analysis (EFA) were conducted to assess factor structure. Results The DS‐II‐J demonstrated high internal consistency ( α = 0.92). Strong positive correlations were found between DS‐II‐J scores and PHQ‐9 and GAD‐7 scores, and moderate correlations with selected ESAS‐r physical symptoms, supporting convergent validity. CFA results showed a suboptimal model fit for both a one‐factor model and the original two‐factor model proposed by Robinson et al. EFA supported a two‐factor structure, but with a different item composition, suggesting cultural influences. Conclusion The DS‐II‐J is a valid and reliable tool for assessing demoralization in Japanese cancer patients.
Tamada et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: